ArticleFrontiers in neurology
Mean systolic blood pressure upon admission and clinical outcomes after endovascular treatment in patients with large vessel occlusion beyond 24 hours.
Article in Frontiers in neurology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and purpose: Recently, several clinical studies have shown that higher systolic blood pressure (SBP) upon admission is associated with poor clinical outcomes in patients with ischemic stroke following endovascular treatment (EVT). However, the effect of the mean systolic blood pressure (MSBP) upon admission on patients with acute anterior circulation large vessel occlusion (ACLVO) who underwent EVT after 24 h is unclear. We sought to assess the association between MSBP at admission and clinical outcomes in patients treated with EVT for acute ACLVO beyond 24 h after onset. Methods: Patients with ACLVO treated with EVT more than 24 h after symptom onset were consecutively enrolled during a 3-year period at a tertiary stroke center. MSBP was measured at admission using an automatic cuff recording. The efficacy outcome was a 3-month good functional outcome (modified Rankin Scale score of 0-2). Symptomatic intracerebral hemorrhage (sICH) and mortality at 3 months were the safety outcomes. Results: A total of 57 patients with acute ischemic stroke who met the inclusion criteria were included in the study (mean age 56 ± 12 years, mean National Institute of Health Stroke Scale score 11 ± 5). In the Firth penalized likelihood logistic regression analyses adjusted for confounding factors, higher MSBP levels were significantly negatively correlated with good clinical outcomes (odds ratio: 0.012; 95% confidence interval: 0.000-0.204). There was no significant association between high SBP and sICH or mortality. Conclusion: Our study suggests that higher MSBP at admission is an independent predictor of a poor clinical outcome at 3 months in patients treated with EVT for acute ACLVO beyond 24 h after onset.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.